Brief: Akoustis Technologies On Sept 9, District Court Issued Order Granting In Part & Denying In Part Qorvo's Motion For Attorneys' Fees
Akoustis Technologies Inc AKTS.O :
* AKOUSTIS TECHNOLOGIES: ON SEPT 9, DISTRICT COURT ISSUED
ORDER
GRANTING IN PART & DENYING IN PART QORVO'S MOTION FOR ATTORNEYS'
FEES
* AKOUSTIS TECHNOLOGIES: DISTRICT COURT ORDER AWARDED QORVO
ABOUT
$11.7 MILLION IN ATTORNEYS' FEES
* AKOUSTIS TECHNOLOGIES: AS OF SEPT 9, DISTRICT COURT HAD
NOT YET
RULED ON CO'S POST-TRIAL MOTIONS OR ON QORVO'S OTHER POST-TRIAL
MOTIONS
Source text for Eikon: ID:n0001213900-24-077421
Further company coverage: AKTS.O
Recent news on Aktis Oncology
See all newsAktis Oncology Q2 net loss widens on higher R&D, administrative costs
U.S. RESEARCH ROUNDUP-Danaher, GM, MSCI
Aktis Oncology Q1 net loss widens on increased IPO-related expenses
Generate Biomedicines shares fall 6% in weak Nasdaq debut for drug developer (updated)
Flagship-backed Generate Biomedicines shares fall 6% in Nasdaq debut